Code
|
0819E
|
MA number
|
EU/1/15/1043/010
|
Product Form:
|
sol inj 3(3x1)x0,4 ml/40 mg (striek.inj.napl.skl.-multibal.)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
GlaxoSmithKline Trading Services Limited, Ireland
|
Therapeutic Class:
|
14 - BRONCHODILATANTIA, ANTIASTHMATICA
|
ATC:
|
R |
RESPIRATORY SYSTEM |
R03 |
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
R03D |
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
R03DX |
Other systemic drugs for obstructive airway diseases |
R03DX09 |
Mepolizumab |
|
Shelf life:
|
36 |
Route of admin.:
|
Subcutaneous use
|